These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 2182211)

  • 1. Macrophages and cancer.
    Whitworth PW; Pak CC; Esgro J; Kleinerman ES; Fidler IJ
    Cancer Metastasis Rev; 1990 Feb; 8(4):319-51. PubMed ID: 2182211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of disseminated melanoma by liposome-activated macrophages.
    Fidler IJ
    World J Surg; 1992; 16(2):270-6. PubMed ID: 1561809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage therapy of cancer metastasis.
    Fidler IJ
    Ciba Found Symp; 1988; 141():211-22. PubMed ID: 3075934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators.
    Killion JJ; Fidler IJ
    Pharmacol Ther; 1998 Jun; 78(3):141-54. PubMed ID: 9690815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362.
    Dinney CP; Bucana CD; Utsugi T; Fidler IJ; von Eschenbach AC; Killion JJ
    Cancer Res; 1991 Jul; 51(14):3741-7. PubMed ID: 1905975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic targeting of liposome-encapsulated immunomodulators to macrophages for treatment of cancer metastasis.
    Killion JJ; Fidler IJ
    Immunomethods; 1994 Jun; 4(3):273-9. PubMed ID: 7820457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
    Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
    Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages and cancer metastasis.
    Fidler IJ; Poste G
    Adv Exp Med Biol; 1982; 155():65-75. PubMed ID: 6984285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal delivery of biological response modifiers to macrophages.
    Pak CC; Fidler IJ
    Biotherapy; 1991; 3(1):55-64. PubMed ID: 2009214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages in cancer metastases and their relevance to metastatic growth.
    Key ME
    Cancer Metastasis Rev; 1983; 2(1):75-88. PubMed ID: 6352008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase.
    Xie K; Fidler IJ
    Cancer Metastasis Rev; 1998 Mar; 17(1):55-75. PubMed ID: 9544423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
    Kleinerman ES
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):927-38. PubMed ID: 7490249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery to macrophages for the therapy of cancer and infectious diseases.
    Kirsh R; Bugelski PJ; Poste G
    Ann N Y Acad Sci; 1987; 507():141-54. PubMed ID: 3327409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes.
    Eue I; Kumar R; Dong Z; Killion JJ; Fidler IJ
    J Immunother; 1998 Sep; 21(5):340-51. PubMed ID: 9789196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease.
    Fidler IJ; Poste G
    Springer Semin Immunopathol; 1982; 5(2):161-74. PubMed ID: 6755782
    [No Abstract]   [Full Text] [Related]  

  • 16. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.
    Fidler IJ; Sone S; Fogler WE; Barnes ZL
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1680-4. PubMed ID: 6940181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo modulation of macrophage tumoricidal activity by oral administration of the liposome-encapsulated macrophage activator CGP 19835A.
    Tanguay S; Bucana CD; Wilson MR; Fidler IJ; von Eschenbach AC; Killion JJ
    Cancer Res; 1994 Nov; 54(22):5882-8. PubMed ID: 7954418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
    Fogler WE; Fidler IJ
    Cancer Res; 1985 Jan; 45(1):14-8. PubMed ID: 3855280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
    Fidler IJ; Schroit AJ
    J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides.
    Hoedemakers RM; Vossebeld PJ; Daemen T; Scherphof GL
    J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):252-60. PubMed ID: 8334109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.